NASDAQ: TARAProtara Therapeutics Inc Stock Ownership - Who owns Protara Therapeutics?
Insider buying vs selling
Have Protara Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Richard S. Levy | Director | 2025-05-14 | 20,000 | $3.19 | $63.80kBuy |
| Richard S. Levy | Director | 2025-05-14 | 20,000 | $3.19 | $63.80kBuy |
| Richard S. Levy | Director | 2025-05-14 | 20,000 | $3.19 | $63.80kBuy |
| Jacqueline Zummo | Chf Scientific Operations Off | 2025-03-26 | 21,224 | $4.53 | $96.14kSell |
| Jesse Shefferman | CEO and President | 2025-01-21 | 15,469 | $4.76 | $73.63kSell |
| Hannah Fry | VP Controller | 2025-01-21 | 2,130 | $4.76 | $10.14kSell |
| Jacqueline Zummo | Chf Scientific Operations Off | 2025-01-21 | 6,554 | $4.76 | $31.20kSell |
| Patrick Fabbio | Chief Financial Officer | 2025-01-21 | 3,061 | $4.76 | $14.57kSell |
| Hannah Fry | VP Controller | 2025-01-03 | 394 | $6.14 | $2.42kSell |
| Jesse Shefferman | CEO and President | 2025-01-03 | 6,479 | $6.14 | $39.78kSell |
TARA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TARA insiders and whales buy or sell their stock.
TARA Shareholders
What type of owners hold Protara Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Hubert Birner | 14.60% | 5,632,802 | $28.67M | Insider |
| Abingworth LLP | 10.79% | 4,162,389 | $21.19M | Insider |
| Janus Henderson Group PLC | 10.63% | 4,102,620 | $20.88M | Institution |
| Tvm Life Science Ventures VI Gmbh Co Kg | 9.97% | 3,846,186 | $19.58M | Insider |
| John Gordon Freund | 9.35% | 3,608,812 | $18.37M | Insider |
| James E. Flynn | 6.28% | 2,422,745 | $12.33M | Insider |
| Timothy Haines | 5.56% | 2,144,517 | $10.92M | Insider |
| Blackrock Inc | 5.56% | 2,143,880 | $10.91M | Institution |
| Velan Capital Investment Management LP | 5.54% | 2,139,000 | $10.89M | Institution |
| Opaleye Management Inc | 5.16% | 1,989,134 | $10.12M | Insider |
TARA vs Biotech Stocks
Protara Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.